Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growth

Kiran Mazumdar-Shaw emphasized the importance of building an innovation-driven pharmaceutical industry in India. She highlighted the need for continued investment in research and regulatory reforms to enhance drug development. The industry must focus on maintaining high-quality standards as it seeks to innovate. Closer cooperation between industry and regulators can help sustain momentum during this transition. India has the potential to...